RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: bone resorption disease
Accession: DOID:0080011
browse the term
Definition: Bone loss due to osteoclastic activity.
Synonyms: exact_synonym: Bone Resorption; Bone Resorptions; Osteoclastic Bone Loss; Osteoclastic Bone Losses
primary_id: MESH:D001862 ; RDO:0004788
For additional species annotation, visit the
Alliance of Genome Resources .
GViewer not supported for chinchilla.
G
Ahr
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19934163
NCBI chrNW_004955410:20,428,531...20,459,482
G
Bmp7
bone morphogenetic protein 7
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17513972
NCBI chrNW_004955445:2,154,057...2,235,594
Ensembl chrNW_004955445:2,153,170...2,235,795
G
Col2a1
collagen type II alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27028940
NCBI chrNW_004955500:6,860,771...6,885,466
Ensembl chrNW_004955500:6,860,771...6,885,473
G
Ghrl
ghrelin and obestatin prepropeptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29477364
NCBI chrNW_004955561:1,676,475...1,682,205
Ensembl chrNW_004955561:1,676,576...1,681,812
G
LOC102023780
aromatase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11985600
NCBI chrNW_004955409:3,198,622...3,313,072
Ensembl chrNW_004955409:3,266,233...3,313,142
G
Pth
parathyroid hormone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9881647
NCBI chrNW_004955414:28,828,389...28,831,417
Ensembl chrNW_004955414:28,825,651...28,831,117
G
Pthlh
parathyroid hormone like hormone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16769263
NCBI chrNW_004955505:6,834,533...6,846,909
Ensembl chrNW_004955505:6,834,533...6,847,335
G
Tnfrsf11b
TNF receptor superfamily member 11b
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:15845617 PMID:18496637 PMID:23333834
NCBI chrNW_004955417:24,804,708...24,831,338
Ensembl chrNW_004955417:24,804,664...24,831,894
G
Tnfsf11
TNF superfamily member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26319416
NCBI chrNW_004955518:431,401...462,063
Ensembl chrNW_004955518:430,642...462,705
G
Smad4
SMAD family member 4
ISO
associated with Juvenile Polyposis Syndrome;DNA:nonsense mutation:exon:p.Y412X (1236C>G) (human)
RGD
PMID:15990641
RGD:12880041
NCBI chrNW_004955402:35,956,080...36,001,746
Ensembl chrNW_004955402:35,961,165...35,994,538
G
Zmpste24
zinc metallopeptidase STE24
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12913070 PMID:17152860
NCBI chrNW_004955537:82,724...134,609
Ensembl chrNW_004955537:81,920...134,609
G
Alpl
alkaline phosphatase, biomineralization associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20630305
NCBI chrNW_004955452:1,820,212...1,873,877
Ensembl chrNW_004955452:1,820,174...1,874,226
G
Ccr2
C-C motif chemokine receptor 2
ISO
associated with Periodontitis;
RGD
PMID:21241302
RGD:8661687
NCBI chrNW_004955420:25,641,184...25,664,413
G
Il10
interleukin 10
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:26270535
RGD:11049527
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
G
Parp1
poly(ADP-ribose) polymerase 1
ISO
RGD
PMID:14630900
RGD:10413909
NCBI chrNW_004955489:520,875...557,609
Ensembl chrNW_004955489:520,875...557,615
G
Tnf
tumor necrosis factor
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:26270535
RGD:11049527
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
G
Tnfsf11
TNF superfamily member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19249596
NCBI chrNW_004955518:431,401...462,063
Ensembl chrNW_004955518:430,642...462,705
G
Tnfrsf11a
TNF receptor superfamily member 11a
ISO
OMIM
NCBI chrNW_004955402:46,242,329...46,298,157
Ensembl chrNW_004955402:46,264,164...46,296,368
G
Notch2
notch receptor 2
ISO
OMIM
NCBI chrNW_004955568:1,660,357...1,812,285
Ensembl chrNW_004955568:1,660,731...1,809,173
G
F12
coagulation factor XII
ISO
ClinVar Annotator: match by term: Hypophosphatemic Nephrolithiasis/Osteoporosis ClinVar Annotator: match by term: Nephrolithiasis/osteoporosis, hypophosphatemic
ClinVar
PMID:8528215 PMID:9354665 PMID:21920016 PMID:23348723 PMID:24029428 PMID:24033266 PMID:25524745 PMID:25741868 PMID:28492532
NCBI chrNW_004955408:29,644,279...29,665,161
Ensembl chrNW_004955408:29,642,096...29,650,950
G
Slc34a1
solute carrier family 34 member 1
ISO
ClinVar Annotator: match by term: Hypophosphatemic Nephrolithiasis/Osteoporosis ClinVar Annotator: match by term: Nephrolithiasis/osteoporosis, hypophosphatemic
ClinVar
PMID:8528215 PMID:9354665 PMID:21920016 PMID:23348723 PMID:24029428 PMID:24033266 PMID:25524745 PMID:25741868 PMID:28492532
NCBI chrNW_004955408:29,626,775...29,640,811
Ensembl chrNW_004955408:29,626,775...29,640,875
G
F12
coagulation factor XII
ISO
ClinVar Annotator: match by term: Nephrolithiasis/osteoporosis, hypophosphatemic, 1
ClinVar
PMID:28492532
NCBI chrNW_004955408:29,644,279...29,665,161
Ensembl chrNW_004955408:29,642,096...29,650,950
G
Slc34a1
solute carrier family 34 member 1
ISO
OMIM
NCBI chrNW_004955408:29,626,775...29,640,811
Ensembl chrNW_004955408:29,626,775...29,640,875
G
Slc9a3r1
SLC9A3 regulator 1
ISO
OMIM
NCBI chrNW_004955553:1,639,267...1,656,850
Ensembl chrNW_004955553:1,639,267...1,656,850
G
Lrp5
LDL receptor related protein 5
ISO
DNA:mutations:exon:c.3446 T > A (p.L1149Q),c.3553 G > A (p.G1185R)(human)
RGD
PMID:22487062
RGD:12793058
NCBI chrNW_004955422:17,394,371...17,475,244
Ensembl chrNW_004955422:17,394,371...17,505,763
G
Ctsc
cathepsin C
ISO
OMIM
NCBI chrNW_004955414:5,062,355...5,092,631
Ensembl chrNW_004955414:5,062,355...5,092,154
G
Lmna
lamin A/C
ISO
OMIM
NCBI chrNW_004955545:2,290,076...2,310,982
Ensembl chrNW_004955545:2,290,037...2,313,033
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18554282
NCBI chrNW_004955445:11,295,500...11,303,322
Ensembl chrNW_004955445:11,295,448...11,303,288
G
Zmpste24
zinc metallopeptidase STE24
ISO
ClinVar Annotator: match by term: Mandibuloacral dysostosis
ClinVar
NCBI chrNW_004955537:82,724...134,609
Ensembl chrNW_004955537:81,920...134,609
G
Mafb
MAF bZIP transcription factor B
ISO
OMIM
NCBI chrNW_004955445:16,219,675...16,222,913
G
Banf1
BAF nuclear assembly factor 1
ISO
OMIM
NCBI chrNW_004955422:19,337,038...19,338,824
Ensembl chrNW_004955422:19,337,038...19,338,824
G
Eif1ad
eukaryotic translation initiation factor 1A domain containing
ISO
ClinVar Annotator: match by term: Nestor-Guillermo progeria syndrome
ClinVar
NCBI chrNW_004955422:19,339,111...19,343,673
Ensembl chrNW_004955422:19,339,111...19,345,109
G
Antxr2
ANTXR cell adhesion molecule 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12973667
NCBI chrNW_004955433:4,212,729...4,345,611
Ensembl chrNW_004955433:4,212,729...4,345,066
G
Ibsp
integrin binding sialoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22407340
NCBI chrNW_004955474:2,074,659...2,086,289
Ensembl chrNW_004955474:2,074,659...2,086,289
G
Mmp2
matrix metallopeptidase 2
ISO
OMIM:277950, Winchester syndrome
RGD
PMID:16542393
RGD:1601416
NCBI chrNW_004955433:13,024,844...13,050,041
Ensembl chrNW_004955433:13,024,418...13,052,775
G
Mmp7
matrix metallopeptidase 7
ISO
associated with Prostatic Neoplasms
RGD
PMID:15894268
RGD:9685352
NCBI chrNW_004955412:5,780,772...5,792,485
Ensembl chrNW_004955412:5,778,502...5,792,445
G
Pthlh
parathyroid hormone like hormone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11054717
NCBI chrNW_004955505:6,834,533...6,846,909
Ensembl chrNW_004955505:6,834,533...6,847,335
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22407340
NCBI chrNW_004955474:1,914,477...1,922,025
Ensembl chrNW_004955474:1,913,829...1,922,016
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15878362
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
G
Tnfrsf11b
TNF receptor superfamily member 11b
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12548581
NCBI chrNW_004955417:24,804,708...24,831,338
Ensembl chrNW_004955417:24,804,664...24,831,894
G
Tnfsf11
TNF superfamily member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18606716
NCBI chrNW_004955518:431,401...462,063
Ensembl chrNW_004955518:430,642...462,705
G
Lpcat2
lysophosphatidylcholine acyltransferase 2
ISO
ClinVar Annotator: match by term: Multicentric osteolysis, nodulosis and arthropathy
ClinVar
NCBI chrNW_004955433:13,052,480...13,120,197
Ensembl chrNW_004955433:13,052,605...13,119,775
G
Mmp2
matrix metallopeptidase 2
ISO
OMIM
NCBI chrNW_004955433:13,024,844...13,050,041
Ensembl chrNW_004955433:13,024,418...13,052,775
G
Abl1
ABL proto-oncogene 1, non-receptor tyrosine kinase
ISO
RGD
PMID:10700189
RGD:10047094
NCBI chrNW_004955513:652,048...799,182
Ensembl chrNW_004955513:653,252...799,239
G
Actg1
actin gamma 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955506:1,546,678...1,549,611
Ensembl chrNW_004955506:1,546,678...1,552,105
G
Ager
advanced glycosylation end-product specific receptor
ISO
mRNA:increased expression:proximal end of left femur (rat)
RGD
PMID:21542009 PMID:22036861
RGD:6767561 RGD:7245948
NCBI chrNW_004955437:645,482...648,607
Ensembl chrNW_004955437:645,897...648,479
G
Antxr2
ANTXR cell adhesion molecule 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12973667
NCBI chrNW_004955433:4,212,729...4,345,611
Ensembl chrNW_004955433:4,212,729...4,345,066
G
Anxa2
annexin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955450:14,545,586...14,574,161
Ensembl chrNW_004955450:14,512,381...14,574,696
G
Ar
androgen receptor
treatment
ISO
RGD
PMID:14600402 PMID:18847323
RGD:10043196 RGD:10043198
NCBI chrNW_004955475:7,013,960...7,192,473
Ensembl chrNW_004955475:7,013,960...7,186,069
G
Atic
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955457:704,213...729,702
Ensembl chrNW_004955457:704,213...730,134
G
Atm
ATM serine/threonine kinase
ISO
RGD
PMID:16644862
RGD:10047420
NCBI chrNW_004955412:10,422,753...10,531,406
Ensembl chrNW_004955412:10,426,135...10,530,545
G
Atp4b
ATPase H+/K+ transporting subunit beta
treatment
ISO
RGD
PMID:26869358
RGD:14696735
NCBI chrNW_004955404:362,410...372,077
Ensembl chrNW_004955404:362,368...372,077
G
Bax
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:22648569
RGD:10054093
NCBI chrNW_004955559:1,695,960...1,700,246
Ensembl chrNW_004955559:1,695,960...1,700,244
G
Bcl2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:22648569
RGD:10054093
NCBI chrNW_004955402:46,911,125...47,084,214
Ensembl chrNW_004955402:46,916,266...47,084,485
G
Bglap
bone gamma-carboxyglutamate protein
susceptibility
ISO
associated with Diabetes Mellitus, type 2;associated with Diabetes Mellitus, type 2; protein:uncercarboxylated:serum DNA:SNP, haplotype:promoter:g.-298C>T (human)
RGD
PMID:15108065 PMID:21550389 PMID:23137636
RGD:10045665 RGD:6483552 RGD:6483579
NCBI chrNW_004955545:2,381,091...2,382,114
Ensembl chrNW_004955545:2,381,156...2,381,978
G
Bmp2
bone morphogenetic protein 2
ISO
RGD
PMID:17002564
RGD:1625350
NCBI chrNW_004955415:17,048,374...17,058,172
Ensembl chrNW_004955415:17,048,030...17,060,181
G
Ca2
carbonic anhydrase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955417:3,388,110...3,402,798
Ensembl chrNW_004955417:3,386,087...3,402,363
G
Calcr
calcitonin receptor
susceptibility
ISO
DNA:SNP:cds:g.1340T>C (human)
OMIM RGD
PMID:23137636
RGD:10045665
NCBI chrNW_004955432:10,310,776...10,391,029
Ensembl chrNW_004955432:10,309,263...10,391,141
G
Cap1
cyclase associated actin cytoskeleton regulatory protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955452:17,503,530...17,528,049
Ensembl chrNW_004955452:17,503,531...17,528,049
G
Cct2
chaperonin containing TCP1 subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955405:9,892,089...9,904,407
Ensembl chrNW_004955405:9,892,116...9,904,407
G
Clec11a
C-type lectin domain containing 11A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27976999
NCBI chrNW_004955559:515,341...517,521
Ensembl chrNW_004955559:514,134...517,787
G
Col1a1
collagen type I alpha 1 chain
susceptibility
ISO
DNA:SNP, haplotype:intron:g.2046G>T (human)
OMIM RGD
PMID:23137636
RGD:10045665
NCBI chrNW_004955451:11,468,156...11,484,410
Ensembl chrNW_004955451:11,468,290...11,483,073
G
Col1a2
collagen type I alpha 2 chain
ISO
OMIM
NCBI chrNW_004955432:11,127,961...11,164,145
Ensembl chrNW_004955432:11,128,112...11,163,302
G
Ctsk
cathepsin K
ISO
RGD
PMID:10469835
RGD:734856
NCBI chrNW_004955588:149,036...158,093
Ensembl chrNW_004955588:148,748...158,093
G
Cxcr4
C-X-C motif chemokine receptor 4
ISO
RGD
PMID:29882473
RGD:14700776
NCBI chrNW_004955440:3,456,165...3,460,024
Ensembl chrNW_004955440:3,455,153...3,460,109
G
Daam2
dishevelled associated activator of morphogenesis 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30598549
NCBI chrNW_004955437:6,728,703...6,839,903
Ensembl chrNW_004955437:6,728,523...6,839,903
G
Dbp
D-box binding PAR bZIP transcription factor
ISO
RGD
PMID:17002564
RGD:1625350
NCBI chrNW_004955559:1,915,424...1,921,322
Ensembl chrNW_004955559:1,916,018...1,921,075
G
Dspp
dentin sialophosphoprotein
ISO
protein:decreased expression:incisor dental pulp (rat)
RGD
PMID:23974864
RGD:12911019
NCBI chrNW_004955474:2,254,842...2,259,303
G
Eno1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955486:4,275,371...4,287,152
Ensembl chrNW_004955486:4,274,238...4,289,809
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
ISO
RGD
PMID:23281008
RGD:10045609
NCBI chrNW_004955555:2,393,510...2,430,180
Ensembl chrNW_004955555:2,393,278...2,406,582
G
Esr1
estrogen receptor 1
no_association treatment
ISO
DNA:SNP, haplotype:intron:g.938C>T (human) DNA:repeat:intron:IVS5+225(CA)18-25 (human) DNA:SNP:intron:397T>C (human) DNA:SNP:exon:2014G>A (human) DNA:repeat:5' utr:g.-1174(TA)10-27 (human) DNA:SNPs:intron: (rs2234693, rs9340799) (human)
RGD
PMID:10773580 PMID:16530497 PMID:16955786 PMID:17896124 PMID:17953702 PMID:20116372 PMID:21421090 PMID:23137636
RGD:10045665 RGD:10045825 RGD:10045826 RGD:10045828 RGD:10045834 RGD:10045839 RGD:10045841 RGD:8694129
NCBI chrNW_004955439:9,588,631...9,953,606
Ensembl chrNW_004955439:9,588,201...9,963,353
G
Esr2
estrogen receptor 2
susceptibility treatment
ISO
DNA:SNP, haplotypes: :-1213T>C (human) DNA:SNP, haplotype:3'utr:*39A>G (human) DNA:repeat:3' utr: g.dupCA (human)
RGD
PMID:16530497 PMID:16777502 PMID:16955786 PMID:21421090 PMID:22948905
RGD:10045825 RGD:10045841 RGD:1626507 RGD:7364765 RGD:8694129
NCBI chrNW_004955466:5,587,003...5,644,765
Ensembl chrNW_004955466:5,575,088...5,638,946
G
Esrra
estrogen related receptor alpha
ISO
RGD
PMID:19936213
RGD:10401868
NCBI chrNW_004955422:20,768,450...20,775,205
Ensembl chrNW_004955422:20,768,450...20,787,451
G
Fga
fibrinogen alpha chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955471:8,806,964...8,814,671
Ensembl chrNW_004955471:8,806,650...8,816,791
G
Fgb
fibrinogen beta chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955471:8,824,901...8,832,836
Ensembl chrNW_004955471:8,822,965...8,832,884
G
G6pd
glucose-6-phosphate dehydrogenase
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18
ClinVar
PMID:5448 PMID:1303173 PMID:1631957 PMID:1978554 PMID:2321910 PMID:2503817 PMID:2572288 PMID:2836867 PMID:3393536 PMID:3446582 PMID:4359638 PMID:4388132 PMID:6015571 PMID:7949118 PMID:8611726 PMID:8860013 PMID:9858856 PMID:10734064 PMID:12367584 PMID:12737938 PMID:14278484 PMID:16356170 PMID:25741868 PMID:26633385 PMID:27287612 PMID:28492532
NCBI chrNW_004955580:1,045,294...1,058,129
Ensembl chrNW_004955580:1,045,294...1,057,083
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955413:4,162,467...4,166,783
Ensembl chrNW_004955413:4,162,467...4,166,783
G
Ghr
growth hormone receptor
treatment
ISO
associated with Uremia;protein:altered expression:osteoblast, osteoclast, chondroblast associated with Cholestasis
RGD
PMID:17647196 PMID:19424739
RGD:10003128 RGD:10003131
NCBI chrNW_004955426:26,553,509...26,873,619
Ensembl chrNW_004955426:26,689,581...26,871,684
G
Gorab
golgin, RAB6 interacting
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18997784
NCBI chrNW_004955462:6,807,618...6,824,296
Ensembl chrNW_004955462:6,807,707...6,825,935
G
Gpc6
glypican 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28869591
NCBI chrNW_004955404:15,429,811...16,504,973
Ensembl chrNW_004955404:15,433,962...16,504,351
G
Gpd2
glycerol-3-phosphate dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955449:16,695,855...16,804,184
Ensembl chrNW_004955449:16,695,435...16,802,908
G
Gpx1
glutathione peroxidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955532:1,298,336...1,298,830
G
Gsn
gelsolin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955419:6,682,202...6,733,361
Ensembl chrNW_004955419:6,682,058...6,733,361
G
Gsr
glutathione-disulfide reductase
ISO
protein:decreased expression:blood
RGD
PMID:19464221
RGD:10401828
NCBI chrNW_004955463:7,130,459...7,153,631
Ensembl chrNW_004955463:7,131,364...7,153,583
G
Gstp1
glutathione S-transferase pi 1
ISO
associated with Cystic Fibrosis;DNA:missense mutation:cds:c.313A>G (p.I105V) (human)
RGD
PMID:24593045
RGD:10401929
NCBI chrNW_004955422:17,914,228...17,916,918
Ensembl chrNW_004955422:17,914,305...17,917,428
G
Hfe
homeostatic iron regulator
ISO
associated with hemochromatosis
RGD
PMID:26829642
RGD:14746963
NCBI chrNW_004955483:933,269...941,070
Ensembl chrNW_004955483:932,352...941,143
G
Htr2c
5-hydroxytryptamine receptor 2C
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18
ClinVar
PMID:24088041 PMID:26633545
NCBI chrNW_004955490:912,615...1,126,347
Ensembl chrNW_004955490:910,415...1,126,373
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955416:15,197,611...15,212,919
Ensembl chrNW_004955416:15,197,366...15,223,363
G
Igf1
insulin like growth factor 1
treatment
ISO
associated with Uremia;protein:altered expression:osteoblast, osteoclast, chondroblast associated with Diabetes Mellitus, Experimental associated with Cholestasis
RGD
PMID:1466160 PMID:10499542 PMID:17647196 PMID:19424739
RGD:10003127 RGD:10003128 RGD:10003131 RGD:10003132
NCBI chrNW_004955405:37,505,830...37,582,152
Ensembl chrNW_004955405:37,512,201...37,582,152
G
Igf1r
insulin like growth factor 1 receptor
ISO
RGD
PMID:18079194
RGD:10045888
NCBI chrNW_004955416:26,101,090...26,382,660
Ensembl chrNW_004955416:26,102,628...26,382,666
G
Igf2
insulin like growth factor 2
treatment
ISO
RGD
PMID:12162999
RGD:10402555
NCBI chrNW_004955422:13,880,525...13,907,963
Ensembl chrNW_004955422:13,880,471...13,888,566
G
Igfbp3
insulin like growth factor binding protein 3
ISO
protein:decreased expression:serum
RGD
PMID:9284698
RGD:10402579
NCBI chrNW_004955456:6,795,560...6,802,147
Ensembl chrNW_004955456:6,795,604...6,800,845
G
Il13ra2
interleukin 13 receptor subunit alpha 2
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18
ClinVar
PMID:24088041 PMID:26633545
NCBI chrNW_004955490:708,144...758,195
Ensembl chrNW_004955490:709,446...758,272
G
Il1a
interleukin 1 alpha
ISO
associated with Arthritis, Rheumatoid
RGD
PMID:10555884
RGD:6907107
NCBI chrNW_004955470:1,527,710...1,538,418
Ensembl chrNW_004955470:1,527,674...1,538,466
G
Il1b
interleukin 1 beta
ISO
RGD
PMID:22997530
RGD:7204491
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:8182127
RGD:8551834
NCBI chrNW_004955470:1,145,022...1,159,413
Ensembl chrNW_004955470:1,144,810...1,159,471
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15995586
NCBI chrNW_004955410:25,079,835...25,084,390
G
Il6r
interleukin 6 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15995586
NCBI chrNW_004955545:932,814...979,359
Ensembl chrNW_004955545:950,765...981,762
G
Irs1
insulin receptor substrate 1
ISO
mRNA, protein:decreased expression:multiple
RGD
PMID:22820932
RGD:7207063
NCBI chrNW_004955453:7,685,715...7,742,262
Ensembl chrNW_004955453:7,685,715...7,742,262
G
Irs2
insulin receptor substrate 2
ISO
associated with Diabetes Mellitus, Type 2; protein:decreased expression:liver,kidney, muscle:
RGD
PMID:22820932
RGD:7207063
NCBI chrNW_004955404:2,531,484...2,555,383
Ensembl chrNW_004955404:2,531,484...2,555,689
G
Kl
klotho
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9363890
RGD:10403047
NCBI chrNW_004955431:12,782,913...12,833,215
Ensembl chrNW_004955431:12,782,846...12,833,215
G
Lep
leptin
treatment
ISO
protein:increased expression:serum (rat) human protein in a rat model associated with chronic obstructive pulmonary disease; protein:decreased expression:serum
RGD
PMID:11459801 PMID:12609558 PMID:21376149 PMID:24250662
RGD:10053572 RGD:10053615 RGD:10053630 RGD:5128771
NCBI chrNW_004955479:9,266,604...9,276,568
Ensembl chrNW_004955479:9,274,516...9,279,472
G
Lepr
leptin receptor
susceptibility
ISO
DNA:polymorphisms:cds:p.K109R,Q223R(human)
RGD
PMID:23460508
RGD:10411886
NCBI chrNW_004955423:25,108,897...25,185,315
Ensembl chrNW_004955423:25,111,266...25,185,407
G
Lgr4
leucine rich repeat containing G protein-coupled receptor 4
susceptibility
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 17 CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:23644456
NCBI chrNW_004955476:6,611,102...6,629,294
Ensembl chrNW_004955476:6,610,103...6,629,264
G
LOC102011010
steroid 17-alpha-hydroxylase/17,20 lyase
ISO
DNA:snps:multiple (human)
RGD
PMID:17002564
RGD:1625350
NCBI chrNW_004955485:7,615,132...7,652,899
Ensembl chrNW_004955485:7,645,363...7,650,658
G
LOC102013768
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22337913
NCBI chrNW_004955445:4,874,583...4,891,723
Ensembl chrNW_004955445:4,873,942...4,891,780
G
LOC102023780
aromatase
ISO
DNA:snps:multiple (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17002564 PMID:20723554
RGD:1625350
NCBI chrNW_004955409:3,198,622...3,313,072
Ensembl chrNW_004955409:3,266,233...3,313,142
G
Lrch2
leucine rich repeats and calponin homology domain containing 2
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18
ClinVar
PMID:24088041 PMID:26633545
NCBI chrNW_004955490:569,526...678,626
Ensembl chrNW_004955490:571,679...676,059
G
Lrp5
LDL receptor related protein 5
treatment
ISO
OMIM RGD
PMID:21977807 PMID:22704852
RGD:12793063 RGD:7240519
NCBI chrNW_004955422:17,394,371...17,475,244
Ensembl chrNW_004955422:17,394,371...17,505,763
G
Ltf
lactotransferrin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16648989 PMID:16936800
NCBI chrNW_004955420:25,580,449...25,604,277
Ensembl chrNW_004955420:25,580,359...25,604,331
G
Luzp4
leucine zipper protein 4
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18
ClinVar
PMID:24088041 PMID:26633545
NCBI chrNW_004955490:448,290...490,242
G
Mapk14
mitogen-activated protein kinase 14
treatment
ISO
RGD
PMID:18442314
RGD:10045965
NCBI chrNW_004955437:3,836,331...3,884,083
Ensembl chrNW_004955437:3,838,232...3,884,083
G
Mgll
monoglyceride lipase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955429:15,760,159...15,960,774
Ensembl chrNW_004955429:15,759,540...15,960,835
G
Mmp9
matrix metallopeptidase 9
ISO
associated with osteoporosis; protein:increased expression:serum
RGD
PMID:19411568
RGD:5129553
NCBI chrNW_004955445:11,295,500...11,303,322
Ensembl chrNW_004955445:11,295,448...11,303,288
G
Myc
MYC proto-oncogene, bHLH transcription factor
ISO
RGD
PMID:22704852
RGD:7240519
NCBI chrNW_004955461:2,714,022...2,718,872
Ensembl chrNW_004955461:2,714,022...2,718,982
G
Nog
noggin
ISO
RGD
PMID:12975477
RGD:10414323
NCBI chrNW_004955451:6,192,368...6,193,766
Ensembl chrNW_004955451:6,193,042...6,193,740
G
Nrip1
nuclear receptor interacting protein 1
ISO
DNA:silent mutation, haplotype:p.G75G (human)
RGD
PMID:16530497
RGD:10045825
NCBI chrNW_004955407:16,740,253...16,820,297
Ensembl chrNW_004955407:16,740,253...16,820,297
G
Opa1
OPA1 mitochondrial dynamin like GTPase
ISO
ClinVar Annotator: match by term: Osteoporosis
ClinVar
PMID:25741868
NCBI chrNW_004955420:14,927,490...15,007,082
Ensembl chrNW_004955420:14,923,575...15,007,081
G
Oxct1
3-oxoacid CoA-transferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955426:25,885,518...25,998,187
Ensembl chrNW_004955426:25,885,518...26,003,743
G
P4hb
prolyl 4-hydroxylase subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955506:1,307,932...1,322,011
Ensembl chrNW_004955506:1,307,932...1,324,027
G
Park7
Parkinsonism associated deglycase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955486:4,974,130...4,985,927
Ensembl chrNW_004955486:4,969,497...4,985,885
G
Pcna
proliferating cell nuclear antigen
ISO
protein:increased expression:osteoblast:
RGD
PMID:22550338
RGD:10045656
NCBI chrNW_004955415:15,744,601...15,748,910
Ensembl chrNW_004955415:15,744,601...15,749,673
G
Pdlim4
PDZ and LIM domain 4
ISO
OMIM
NCBI chrNW_004955408:3,638,264...3,647,792
Ensembl chrNW_004955408:3,638,264...3,646,600
G
Pgls
6-phosphogluconolactonase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955524:797,439...801,070
Ensembl chrNW_004955524:793,239...801,107
G
Pkm
pyruvate kinase M1/2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955450:4,907,962...4,935,179
Ensembl chrNW_004955450:4,907,788...4,936,199
G
Plek
pleckstrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955424:16,494,052...16,524,790
Ensembl chrNW_004955424:16,493,960...16,524,998
G
Pls3
plastin 3
ISO
OMIM
NCBI chrNW_004955490:125,913...221,152
Ensembl chrNW_004955490:122,328...221,388
G
Pnp
purine nucleoside phosphorylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955550:1,290,816...1,299,553
Ensembl chrNW_004955550:1,290,244...1,298,068
G
Pomc
proopiomelanocortin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3017235 PMID:4367732 PMID:6143199 PMID:6254450 PMID:19153526
NCBI chrNW_004955469:7,217,233...7,220,401
Ensembl chrNW_004955469:7,217,363...7,220,386
G
Prdx3
peroxiredoxin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955431:23,640,775...23,651,738
Ensembl chrNW_004955431:23,638,765...23,652,191
G
Psma2
proteasome 20S subunit alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955460:880,795...890,718
Ensembl chrNW_004955460:880,715...893,979
G
Psma5
proteasome 20S subunit alpha 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955435:12,823,137...12,845,631
Ensembl chrNW_004955435:12,822,707...12,846,296
G
Ptger4
prostaglandin E receptor 4
treatment
ISO
RGD
PMID:16442794
RGD:10043381
NCBI chrNW_004955426:24,997,811...25,010,822
Ensembl chrNW_004955426:24,997,811...25,010,822
G
Pth
parathyroid hormone
treatment
ISO
CTD Direct Evidence: therapeutic protein:decreased expression:serum (rat)
CTD RGD
PMID:15710971 PMID:17317460 PMID:17882678 PMID:19578808 PMID:21306167 PMID:22312238 PMID:23161222 PMID:30639440
RGD:7242793 RGD:7242907
NCBI chrNW_004955414:28,828,389...28,831,417
Ensembl chrNW_004955414:28,825,651...28,831,117
G
Rab7b
RAB7B, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955406:41,615,302...41,638,157
Ensembl chrNW_004955406:41,615,302...41,638,151
G
Ren
renin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18847324
NCBI chrNW_004955406:40,016,624...40,026,286
Ensembl chrNW_004955406:40,016,630...40,026,286
G
Rsu1
Ras suppressor protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955429:11,043,205...11,234,698
Ensembl chrNW_004955429:11,043,040...11,235,758
G
Ryr1
ryanodine receptor 1
ISO
ClinVar Annotator: match by term: Osteoporosis
ClinVar
PMID:25741868 PMID:28492532
NCBI chrNW_004955468:879,807...1,000,118
Ensembl chrNW_004955468:879,951...1,000,036
G
Sirt1
sirtuin 1
treatment
ISO
RGD
PMID:22555620 PMID:25377437
RGD:10047129 RGD:10053568
NCBI chrNW_004955425:20,280,725...20,307,663
Ensembl chrNW_004955425:20,279,963...20,307,663
G
Sod2
superoxide dismutase 2
susceptibility no_association
ISO
DNA:SNPs:intron, exon:g.31A>G, g.327C>T (p.A16V) (rs5746094, rs4880) (human) CTD Direct Evidence: marker/mechanism DNA:SNPs:5' utr, exon, intron:multiple
RGD CTD
PMID:18924182 PMID:26336112
RGD:11035299
NCBI chrNW_004955439:21,209,101...21,223,538
Ensembl chrNW_004955439:21,209,101...21,224,163
G
Tgfb1
transforming growth factor beta 1
treatment
ISO
CTD Direct Evidence: marker/mechanism associated with Uremia;protein:increased expression:osteoblast, osteoclast
CTD RGD
PMID:12706579 PMID:17647196
RGD:10003128
NCBI chrNW_004955555:274,405...288,441
Ensembl chrNW_004955555:270,652...288,441
G
Tln1
talin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955472:568,939...603,676
Ensembl chrNW_004955472:568,939...603,676
G
Tnfrsf11a
TNF receptor superfamily member 11a
ISO
RGD
PMID:17002564
RGD:1625350
NCBI chrNW_004955402:46,242,329...46,298,157
Ensembl chrNW_004955402:46,264,164...46,296,368
G
Tnfrsf11b
TNF receptor superfamily member 11b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17667143
NCBI chrNW_004955417:24,804,708...24,831,338
Ensembl chrNW_004955417:24,804,664...24,831,894
G
Tnfrsf1b
TNF receptor superfamily member 1B
ISO
RGD
PMID:17002564
RGD:1625350
NCBI chrNW_004955486:1,790,531...1,817,986
Ensembl chrNW_004955486:1,792,115...1,818,362
G
Tnfsf11
TNF superfamily member 11
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:17002564 PMID:17882678
RGD:1625350
NCBI chrNW_004955518:431,401...462,063
Ensembl chrNW_004955518:430,642...462,705
G
Tpi1
triosephosphate isomerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955413:4,467,615...4,471,594
Ensembl chrNW_004955413:4,467,566...4,471,177
G
Tpm4
tropomyosin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955524:1,419,061...1,432,114
Ensembl chrNW_004955524:1,415,848...1,432,139
G
U2af1
U2 small nuclear RNA auxiliary factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955407:38,895,741...38,909,820
G
Vcl
vinculin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955437:17,812,998...17,920,253
Ensembl chrNW_004955437:17,813,007...17,920,253
G
Vdr
vitamin D receptor
no_association
ISO
associated with Cystic Fibrosis
RGD
PMID:16713399
RGD:4889871
NCBI chrNW_004955500:6,745,725...6,798,052
Ensembl chrNW_004955500:6,745,678...6,798,048
G
Wdr1
WD repeat domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chrNW_004955549:2,640,193...2,674,818
Ensembl chrNW_004955549:2,640,195...2,673,969
G
Wnt1
Wnt family member 1
susceptibility
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 16 CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:23499309 PMID:23656646
NCBI chrNW_004955500:7,797,063...7,811,142
Ensembl chrNW_004955500:7,797,060...7,811,167
G
Zdhhc13
zinc finger DHHC-type palmitoyltransferase 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20548961
NCBI chrNW_004955476:105,347...152,415
Ensembl chrNW_004955476:105,347...154,615
G
Pdgfrb
platelet derived growth factor receptor beta
ISO
OMIM
NCBI chrNW_004955415:4,365,848...4,403,317
Ensembl chrNW_004955415:4,365,743...4,403,587
G
Acp5
acid phosphatase 5, tartrate resistant
ISO
protein:increased expression:femur (rat)
RGD
PMID:19736603
RGD:2315910
NCBI chrNW_004955495:2,418,113...2,421,181
Ensembl chrNW_004955495:2,418,364...2,421,538
G
Ar
androgen receptor
ISO
RGD
PMID:12593895
RGD:1578682
NCBI chrNW_004955475:7,013,960...7,192,473
Ensembl chrNW_004955475:7,013,960...7,186,069
G
Bmp15
bone morphogenetic protein 15
susceptibility
ISO
DNA:SNPs, haplotype:5' utr, intron:g.-9C>G, IVS1+905A>G (human)
RGD
PMID:22335445
RGD:10045849
NCBI chrNW_004955543:2,304,112...2,345,376
G
Cat
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17227729
NCBI chrNW_004955422:11,783,973...11,826,970
Ensembl chrNW_004955422:11,781,835...11,827,464
G
Col1a1
collagen type I alpha 1 chain
ISO
ClinVar Annotator: match by term: Postmenopausal osteoporosis
ClinVar
PMID:2037280 PMID:7695699 PMID:7942841 PMID:8218237 PMID:8408653 PMID:8613526 PMID:8669434 PMID:8808594 PMID:9016532 PMID:9067755 PMID:9295084 PMID:9443882 PMID:10931857 PMID:12590186 PMID:15024692 PMID:15024745 PMID:15741671 PMID:15864348 PMID:15931785 PMID:17078022 PMID:17309652 PMID:18412368 PMID:18553566 PMID:18704262 PMID:19344236 PMID:19358256 PMID:21249479 PMID:21567126 PMID:21667357 PMID:22589248 PMID:22753364 PMID:24390061 PMID:25086671 PMID:25741868 PMID:25944380 PMID:25963598 PMID:26177859 PMID:26467025 PMID:27132807 PMID:27509835 PMID:27510842 PMID:27748872 PMID:28378289 PMID:28492532
NCBI chrNW_004955451:11,468,156...11,484,410
Ensembl chrNW_004955451:11,468,290...11,483,073
G
Col1a2
collagen type I alpha 2 chain
ISO
ClinVar Annotator: match by term: Postmenopausal osteoporosis
ClinVar
PMID:1463018 PMID:1978725 PMID:2052622 PMID:2985635 PMID:7695699 PMID:7860070 PMID:8094076 PMID:8218237 PMID:8786074 PMID:9016532 PMID:9272740 PMID:9399846 PMID:9594376 PMID:9923651 PMID:15172002 PMID:16705691 PMID:17078022 PMID:18028452 PMID:19344236 PMID:21520333 PMID:22589248 PMID:25326637 PMID:25450603 PMID:25741868 PMID:25944380 PMID:26432670 PMID:26604951 PMID:27519266 PMID:28492532
NCBI chrNW_004955432:11,127,961...11,164,145
Ensembl chrNW_004955432:11,128,112...11,163,302
G
Esr1
estrogen receptor 1
treatment susceptibility
ISO
DNA:SNP:intron:IVS1T>C (human) DNA:SNPs, haplotype:intron: (rs2234693, rs9340799) (human)
RGD
PMID:16604479 PMID:16972020
RGD:10045838 RGD:8158082
NCBI chrNW_004955439:9,588,631...9,953,606
Ensembl chrNW_004955439:9,588,201...9,963,353
G
Esr2
estrogen receptor 2
susceptibility
ISO
DNA:repeat:intron:IVS5-3919(CA)18-26 (human) DNA:SNP, haplotype:3'utr:*39A>G (human) DNA:SNP: :-1213T>C (human)
RGD
PMID:16777502 PMID:17945165 PMID:22335445
RGD:10045847 RGD:10045849 RGD:1626507
NCBI chrNW_004955466:5,587,003...5,644,765
Ensembl chrNW_004955466:5,575,088...5,638,946
G
Fdps
farnesyl diphosphate synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31774873
NCBI chrNW_004955545:1,757,090...1,765,028
Ensembl chrNW_004955545:1,757,418...1,765,028
G
Fgf23
fibroblast growth factor 23
ISO
protein:increased expression: :
RGD
PMID:24101107
RGD:10044241
NCBI chrNW_004955413:2,182,459...2,192,279
Ensembl chrNW_004955413:2,182,459...2,192,279
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
ISO
RGD
PMID:18067744 PMID:24023068
RGD:10402191 RGD:10402540
NCBI chrNW_004955466:8,000,311...8,022,497
Ensembl chrNW_004955466:8,000,044...8,022,497
G
Igf1
insulin like growth factor 1
ISO
protein:decreased expression:serum:
RGD
PMID:11063288
RGD:10045861
NCBI chrNW_004955405:37,505,830...37,582,152
Ensembl chrNW_004955405:37,512,201...37,582,152
G
Igf2
insulin like growth factor 2
treatment
ISO
RGD
PMID:16753016
RGD:10402556
NCBI chrNW_004955422:13,880,525...13,907,963
Ensembl chrNW_004955422:13,880,471...13,888,566
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9032749
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9032749
NCBI chrNW_004955410:25,079,835...25,084,390
G
Il7
interleukin 7
treatment
ISO
RGD
PMID:23662133
RGD:10402930
NCBI chrNW_004955444:2,365,077...2,400,953
G
LOC102023780
aromatase
ISO
DNA:snps:exon:multiple (human)
RGD
PMID:17118999
RGD:1600860
NCBI chrNW_004955409:3,198,622...3,313,072
Ensembl chrNW_004955409:3,266,233...3,313,142
G
Lrp5
LDL receptor related protein 5
ISO
ClinVar Annotator: match by term: Postmenopausal osteoporosis
ClinVar
PMID:25741868 PMID:28492532
NCBI chrNW_004955422:17,394,371...17,475,244
Ensembl chrNW_004955422:17,394,371...17,505,763
G
Nrip1
nuclear receptor interacting protein 1
susceptibility
ISO
DNA:silent mutation:cds:p.G75G (human)
RGD
PMID:22335445
RGD:10045849
NCBI chrNW_004955407:16,740,253...16,820,297
Ensembl chrNW_004955407:16,740,253...16,820,297
G
Ptger4
prostaglandin E receptor 4
treatment
ISO
RGD
PMID:11917107
RGD:10003045
NCBI chrNW_004955426:24,997,811...25,010,822
Ensembl chrNW_004955426:24,997,811...25,010,822
G
Pth
parathyroid hormone
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20567999
NCBI chrNW_004955414:28,828,389...28,831,417
Ensembl chrNW_004955414:28,825,651...28,831,117
G
Ptk2b
protein tyrosine kinase 2 beta
ISO
RGD
PMID:17537919
RGD:1642610
NCBI chrNW_004955403:49,856,056...49,970,800
Ensembl chrNW_004955403:49,855,541...49,973,225
G
Tgfb1
transforming growth factor beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10750555
NCBI chrNW_004955555:274,405...288,441
Ensembl chrNW_004955555:270,652...288,441
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9032749
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
G
Vdr
vitamin D receptor
treatment
ISO
DNA:SNP:exon: (rs2228570) (human) ClinVar Annotator: match by term: Postmenopausal osteoporosis
RGD ClinVar
PMID:16604479 PMID:25741868
RGD:8158082
NCBI chrNW_004955500:6,745,725...6,798,052
Ensembl chrNW_004955500:6,745,678...6,798,048
G
Ifih1
interferon induced with helicase C domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
NCBI chrNW_004955449:11,538,869...11,596,502
Ensembl chrNW_004955449:11,538,889...11,593,349
G
Ifih1
interferon induced with helicase C domain 1
ISO
OMIM
NCBI chrNW_004955449:11,538,869...11,596,502
Ensembl chrNW_004955449:11,538,889...11,593,349
G
Ddx58
DExD/H-box helicase 58
ISO
OMIM
NCBI chrNW_004955472:3,093,895...3,135,524
Ensembl chrNW_004955472:3,093,939...3,133,987
G
Ddr2
discoidin domain receptor tyrosine kinase 2
ISO
OMIM
NCBI chrNW_004955462:13,578,638...13,644,834
Ensembl chrNW_004955462:13,584,724...13,642,968
G
Mmp14
matrix metallopeptidase 14
ISO
OMIM
NCBI chrNW_004955409:37,438,924...37,448,704
Ensembl chrNW_004955409:37,440,541...37,448,437
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all